{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:18:48Z","timestamp":1670314728746},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,11,9]],"date-time":"2012-11-09T00:00:00Z","timestamp":1352419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s10067-012-2109-y","type":"journal-article","created":{"date-parts":[[2012,11,8]],"date-time":"2012-11-08T05:19:31Z","timestamp":1352351971000},"page":"241-245","source":"Crossref","is-referenced-by-count":2,"title":["Midterm outcome of risedronate therapy for patients with Paget\u2019s disease of bone in the central part of Japan"],"prefix":"10.1007","volume":"32","author":[{"given":"Yoshihiro","family":"Nishida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Tsukushi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideshi","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Urakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,9]]},"reference":[{"issue":"7","key":"2109_CR1","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1359\/jbmr.1998.13.7.1061","volume":"13","author":"ES Siris","year":"1998","unstructured":"Siris ES (1998) Paget\u2019s disease of bone. J Bone Miner Res 13(7):1061\u20131065. doi: 10.1359\/jbmr.1998.13.7.1061","journal-title":"J Bone Miner Res"},{"issue":"6347","key":"2109_CR2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1136\/bmj.285.6347.1005","volume":"285","author":"FM Detheridge","year":"1982","unstructured":"Detheridge FM, Guyer PB, Barker DJ (1982) European distribution of Paget\u2019s disease of bone. Br Med J (Clin Res Ed) 285(6347):1005\u20131008","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2109_CR3","first-page":"535","volume":"54","author":"SR Joshi","year":"2006","unstructured":"Joshi SR, Ambhore S, Butala N, Patwardhan M, Kulkarni M, Pai B, Karne R (2006) Paget\u2019s disease from Western India. J Assoc Phys India 54:535\u2013538","journal-title":"J Assoc Phys India"},{"issue":"5","key":"2109_CR4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00774-006-0696-x","volume":"24","author":"S Takata","year":"2006","unstructured":"Takata S, Hashimoto J, Nakatsuka K, Yoshimura N, Yoh K, Ohno I, Yabe H, Abe S, Fukunaga M, Terada M, Zamma M, Ralston SH, Morii H, Yoshikawa H (2006) Guidelines for diagnosis and management of Paget\u2019s disease of bone in Japan. J Bone Miner Metab 24(5):359\u2013367. doi: 10.1007\/s00774-006-0696-x","journal-title":"J Bone Miner Metab"},{"issue":"9","key":"2109_CR5","first-page":"1031","volume":"117","author":"WC Sturtridge","year":"1977","unstructured":"Sturtridge WC, Harrison JE, Wilson DR (1977) Long-term treatment of Paget\u2019s disease of bone with salmon calcitonin. Can Med Assoc J 117(9):1031\u20131034","journal-title":"Can Med Assoc J"},{"issue":"9","key":"2109_CR6","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJMoa044241","volume":"353","author":"IR Reid","year":"2005","unstructured":"Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D (2005) Comparison of a single infusion of zoledronic acid with risedronate for Paget\u2019s disease. N Engl J Med 353(9):898\u2013908. doi: 10.1056\/NEJMoa044241","journal-title":"N Engl J Med"},{"issue":"4","key":"2109_CR7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0002-9343(96)00227-6","volume":"101","author":"IR Reid","year":"1996","unstructured":"Reid IR, Nicholson GC, Weinstein RS, Hosking DJ, Cundy T, Kotowicz MA, Murphy WA Jr, Yeap S, Dufresne S, Lombardi A, Musliner TA, Thompson DE, Yates AJ (1996) Biochemical and radiologic improvement in Paget\u2019s disease of bone treated with alendronate: a randomized, placebo-controlled trial. Am J Med 101(4):341\u2013348","journal-title":"Am J Med"},{"issue":"4","key":"2109_CR8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00774-009-0152-9","volume":"28","author":"K Yoh","year":"2010","unstructured":"Yoh K, Takata S, Yoshimura N, Hashimoto J (2010) Efficacy, tolerability, and safety of risedronate in Japanese patients with Paget\u2019s disease of bone. J Bone Miner Metab 28(4):468\u2013476. doi: 10.1007\/s00774-009-0152-9","journal-title":"J Bone Miner Metab"},{"issue":"3","key":"2109_CR9","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S8756-3282(02)00817-7","volume":"31","author":"PL Selby","year":"2002","unstructured":"Selby PL, Davie MW, Ralston SH, Stone MD (2002) Guidelines on the management of Paget\u2019s disease of bone. Bone 31(3):366\u2013373","journal-title":"Bone"},{"issue":"6","key":"2109_CR10","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1359\/jbmr.1998.13.6.1032","volume":"13","author":"ES Siris","year":"1998","unstructured":"Siris ES, Chines AA, Altman RD, Brown JP, Johnston CC Jr, Lang R, McClung MR, Mallette LE, Miller PD, Ryan WG, Singer FR, Tucci JR, Eusebio RA, Bekker PJ (1998) Risedronate in the treatment of Paget\u2019s disease of bone: an open label, multicenter study. J Bone Miner Res 13(6):1032\u20131038. doi: 10.1359\/jbmr.1998.13.6.1032","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2109_CR11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bone.2004.03.023","volume":"35","author":"IR Reid","year":"2004","unstructured":"Reid IR, Davidson JS, Wattie D, Wu F, Lucas J, Gamble GD, Rutland MD, Cundy T (2004) Comparative responses of bone turnover markers to bisphosphonate therapy in Paget\u2019s disease of bone. Bone 35(1):224\u2013230. doi: 10.1016\/j.bone.2004.03.023","journal-title":"Bone"},{"issue":"7","key":"2109_CR12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.tem.2008.06.001","volume":"19","author":"T Cundy","year":"2008","unstructured":"Cundy T, Bolland M (2008) Paget disease of bone. Trends Endocrinol Metab 19(7):246\u2013253. doi: 10.1016\/j.tem.2008.06.001","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"2109_CR13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1359\/jbmr.080215","volume":"23","author":"RA Wermers","year":"2008","unstructured":"Wermers RA, Tiegs RD, Atkinson EJ, Achenbach SJ, Melton LJ 3rd (2008) Morbidity and mortality associated with Paget\u2019s disease of bone: a population-based study. J Bone Miner Res 23(6):819\u2013825. doi: 10.1359\/jbmr.080215","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2109_CR14","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1017\/S0022215106002519","volume":"120","author":"I Mackenzie","year":"2006","unstructured":"Mackenzie I, Young C, Fraser WD (2006) Tinnitus and Paget\u2019s disease of bone. J Laryngol Otol 120(11):899\u2013902. doi: 10.1017\/S0022215106002519","journal-title":"J Laryngol Otol"},{"issue":"9430","key":"2109_CR15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(04)16676-2","volume":"364","author":"C Grigor","year":"2004","unstructured":"Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, Kincaid W, Porter D (2004) Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364(9430):263\u2013269. doi: 10.1016\/S0140-6736(04)16676-2","journal-title":"Lancet"},{"issue":"1","key":"2109_CR16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1359\/jbmr.061001","volume":"22","author":"D Hosking","year":"2007","unstructured":"Hosking D, Lyles K, Brown JP, Fraser WD, Miller P, Curiel MD, Devogelaer JP, Hooper M, Su G, Zelenakas K, Pak J, Fashola T, Saidi Y, Eriksen EF, Reid IR (2007) Long-term control of bone turnover in Paget\u2019s disease with zoledronic acid and risedronate. J Bone Miner Res 22(1):142\u2013148. doi: 10.1359\/jbmr.061001","journal-title":"J Bone Miner Res"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2109-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-012-2109-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-012-2109-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:22Z","timestamp":1559120242000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-012-2109-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,9]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["2109"],"URL":"https:\/\/doi.org\/10.1007\/s10067-012-2109-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,9]]}}}